What are the treatment options for neuropathic pain refractory to duloxetine (Cymbalta) and pregabalin (Lyrica)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
DS

Dainyal Siddiqui, MD

Internal Medicine

MJ

Manuel Jimenez, MD

Cardiology

FP

Franz Pierre-Louis, MD

Infectious Disease

Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025 • View editorial policy

From the Guidelines

For neuropathic pain refractory to duloxetine and pregabalin, consider adding or switching to tricyclic antidepressants like amitriptyline (starting at 10-25mg at bedtime, gradually increasing to 25-150mg daily as tolerated) or nortriptyline (10-25mg initially, titrating to 50-150mg daily), as these alternatives have shown efficacy in treating neuropathic pain, according to the most recent and highest quality study 1.

When considering treatment options for neuropathic pain that has not responded to duloxetine and pregabalin, it's essential to evaluate the patient's overall health and potential comorbidities. The treatment approach should be individualized, taking into account the patient's medical history, current medications, and potential side effects of the new treatment options.

Some key points to consider when treating neuropathic pain refractory to duloxetine and pregabalin include:

  • Tricyclic antidepressants, such as amitriptyline and nortriptyline, have been shown to be effective in treating neuropathic pain, with a number needed to treat (NNT) of 1.5-3.5 2.
  • Sodium channel blockers, such as carbamazepine and oxcarbazepine, may also be effective in treating neuropathic pain, although their use may be limited by side effects such as dizziness and somnolence 1.
  • Topical options, such as lidocaine 5% patches or capsaicin 8% patches, may provide localized relief with minimal systemic effects, making them a useful alternative for patients who cannot tolerate oral medications 1.
  • For severe cases, consider opioids like tramadol (50-100mg every 4-6 hours, maximum 400mg daily) or referral for interventional procedures such as spinal cord stimulation or intrathecal drug delivery, although these options should be used with caution due to the risk of addiction and side effects 3.

It's also important to note that combination therapy targeting different pain mechanisms often works better than monotherapy, as different medications can affect multiple neurotransmitters and pathways involved in pain transmission 1.

In terms of specific treatment recommendations, the most recent and highest quality study 1 suggests that tricyclic antidepressants, such as amitriptyline and nortriptyline, may be a good alternative for patients with neuropathic pain refractory to duloxetine and pregabalin. However, it's essential to carefully evaluate the patient's individual needs and medical history before initiating any new treatment.

Overall, the treatment of neuropathic pain refractory to duloxetine and pregabalin requires a comprehensive and individualized approach, taking into account the patient's unique needs and medical history. By considering the latest evidence and treatment options, healthcare providers can help patients achieve optimal pain management and improve their quality of life.

From the Research

Treatment Options for Neuropathic Pain Refractory to Duloxetine and Pregabalin

  • For patients who do not respond to duloxetine and pregabalin, several alternative treatment options are available, including: + Tricyclic antidepressants, such as amitriptyline 4, 5 + Gabapentin 4, 5 + Topical lidocaine and transcutaneous electrical nerve stimulation, specifically for focal peripheral neuropathic pain 4, 5 + Combination therapies, such as tramadol, and psychotherapy as adjuncts 4, 5 + High-concentration capsaicin patches and botulinum toxin A, specifically for focal peripheral neuropathic pain 4, 5
  • In cases where primary and secondary treatments prove insufficient, third-line options may be considered, including: + High-frequency repetitive transcranial magnetic stimulation (rTMS) targeting the motor cortex 4 + Spinal cord stimulation 4 + Strong opioids, when no alternative is available 4, 5
  • A study comparing the efficacy and tolerability of different combinations of first-line drugs for the treatment of diabetic peripheral neuropathic pain found that combination treatment was well tolerated and led to improved pain relief in patients with suboptimal pain control with monotherapy 6
  • Another study demonstrated the non-inferiority of a low-dose fixed-dose combination of pregabalin and duloxetine compared to pregabalin monotherapy in patients with moderate to severe neuropathic pain 7

References

3
Guideline

use and misuse of opioids in chronic pain.

Annual Review of Medicine, 2018

4
Research

Neuropathic pain: Evidence based recommendations.

Presse medicale (Paris, France : 1983), 2024

Related Questions

What antidepressants are used for neuropathic (nerve) pain?
What is the most useful medication for peripheral neuropathy?
What's the best next step for a patient with chronic nerve pain, who's tried duloxetine, amitriptyline, and nortriptyline, and now requests gabapentin or Lyrica (pregabalin), given a history of liver damage?
Is there evidence that Levetiracetam (Keppra) is effective in managing neuropathic back pain?
What are the alternatives to Gabapentin (gabapentin) for managing neuropathic pain in patients with cognitive impairment induced by Gabapentin (gabapentin)?
Is albuterol (salbutamol) appropriate for a patient with suspected early pneumonia and shortness of breath (SOB) who presents with a chest X-ray showing parenchymal opacities at the left lung base?
At what time of day should HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase inhibitors, commonly referred to as statins, be administered?
What is the most likely diagnosis for a 15-year-old sexually active female with a severe occipital headache, abdominal pain, nausea, vomiting, right upper quadrant tenderness, a palpable abdominal mass, hyperreflexia, and elevated serum beta-human chorionic gonadotropin (β-hCG)?
What is the cause of vaginal spotting in a 9-week pregnant woman with a closed cervais (cervical os) and a 14-week-sized uterus?
What is the diagnosis for an undisplaced fracture of the lateral malleolus with a vertical orientation extending to the physis, accompanied by minimal bone marrow edema and a suspected Salter-Harris type 1 (S-H 1) component, with an intact ankle mortise and no ligamentous injury?
What is the diagnosis for an undisplaced fracture of the lateral malleolus with a vertical orientation extending to the physis, accompanied by minimal bone marrow edema and a suspected Salter-Harris type 1 (S-H 1) component, with an intact ankle mortise and no ligamentous injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Ask a new Question. Chat with the Guidelines